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The presentation will begin with a discussion of the rationale 
for the use of respiratory control techniques in breast cancer. 
Data pertaining to the dosimetric gains of breath-hold and 
gating techniques will be reviewed and the expected clinical 
gains will be modelled based on the Darby data (NEJM, 2013). 
The range of respiratory control options will be presented 
and the pros and cons of each technique discussed.  The UK 
HeartSpare Study will be reviewed as an example of how to 
use research to increase national use of heart-sparing breast 
radiotherapy techniques. The presentation will finish with a 
discussion of potential future applications of respiratory 
control techniques and how to integrate them with advanced 
radiotherapeutic approaches. 
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The use of IMRT for many cancers has increased in recent 
years.  In general, IMRT has been shown to improve 
conformality of target volume coverage, with improved high 
dose sparing of organs at risk (OAR), however, at the cost of 
increased volumes of normal tissue receiving lower doses of 
radiation.  Improved treatment planning and delivery 
technology have greatly advanced the practice of IMRT over 
time. 
Among women with breast cancer, two distinct “types” of 
IMRT are used, in very different circumstances with fairly 
well-defined benefits and costs.  Tangential or field in field 
IMRT has been used to improve delivery of chest wall/breast 
radiotherapy.  Inverse planned multifield or arc IMRT has 
been used to improve delivery of chest wall/breast + nodal 
radiotherapy. 
Tangential or field in field IMRT, either inverse or forward 
planned, has been shown to increase the ability of 
radiotherapy departments to improve the quality of 
treatment planning and delivery of tangential breast 
radiotherapy, through more efficient planning processes, 
improved dose homogeneity in the breast, and increased 
automation, while possibly decreasing toxicity.  
Inverse planned multifield or arc IMRT has been shown to 
improve dose conformality, particularly to facilitate inclusion 
of more complex treatment volumes, e.g. chest wall + 
internal mammary nodes,  in the anatomic setting of 
significant OAR, such as the heart and lungs.  Literature 
suggests that this is typically at the cost of higher volumes of 
normal tissue receiving low doses, greater dose 
inhomogeneity, and greater resources required for treatment 
planning and delivery.   
This session will discuss the balance between the benefits 
and downsides of the use of both types of IMRT, review 
potential indications for both, and provide illustrative 
examples of clinical cases and treatment plans. 
 
 
Symposium: Advanced technology assessment: Quality 
management in an era of rapidly evolving radiotherapy 
technology  
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Radiotherapy has a long history of examining the risks and 
documenting adverse events. Pro-active risk assessment and 
the reactive analyses of events should be used in parallel in 
order to provide optimal results for risks management. 
Different methods of risks assessment are available but a 
combination of methods is needed to perform a complete 
evaluation. The reactive (retrospective) analysis of events is 
directly related to the recording and the reporting of events. 
Detailed analyses should be reported through the local 
and/or external reporting system with the primarily purpose 
of more widely disseminating the experience learnt to other 
professionals. It is important to document all funding and 
corrective actions in order to prevent the re-occurrence of 
such events and especially, to share the experience learnt as 
a result of the event. Two levels of recommendations should 
be provided: recommendations to institutions that provide 
radiotherapy services whose primary responsibility is patient 
safety and secondly, to national authorities which focus on 
the needs for strong support at the national or original level 
to promote culture that value risks management and safety. 
In the area of new technologies, educational program and 
practice risk analyses should be favored for the development 
or update the national strategy on quality and risk 
management to promote a safety culture in radiotherapy. 
Clinical audits and regulator inspections are also considered 
to play many important roles in a national strategy. These 
actions are aiming to identify assessing and analyzing and 
understanding on risk issues in order to rich an optimal 
balance of risks benefits and costs. All the actors involved in 
radiotherapy process should be concerned by these 
approaches (physicians, physicists, nurses, radiation 
technologists and companies). The most relevant advice that 
might be recommended to radiation oncologists aiming to 
implement new technologies is to participate to trials 
including a relevant quality assurance program.  
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The professional radiotherapy (RT) team comprised of 
radiation oncologists, medical physicist and radiation 
therapist (RTT) work through an integrated process to plan 
and deliver RT to cancer patients. Each step requires quality 
control (QC) and quality assurance (QA) measures to prevent 
errors and to give high confidence that patients will receive 
the prescribed treatment correctly. Not unlike the other 
professionals, the RTT is involved in a number of QC and QA 
measures. However, RTTs often are the last security barrier 
that will prevent a near incident from becoming an incident 
as they are often the pivot point between the pre-treatment 
phase and the treatment phase of the RT process.  
With the recent advances in RT, including intensity-
modulated and image-guided RT, QA demands on RTTs have 
dramatically increased. While the individualisation of 
treatments, precise positioning verification processes and 
increased in IT complexity have optimized patient treatment 
parameters, they also have resulted in the need for 
